MUMBAI: Drug firm Claris Lifesciences listed at 224.4 rupees on the BSE on Monday, down 1.57 percent from its issue price of 228 rupees a share.
Claris sold 10.78 million shares through its initial public offer (IPO) issue to raise 2.46 billion rupees.
Enam Securities , Edelweiss Capital , JM Financial Consultants and ICICI Securities were the arrangers to the issue.
At 9:28 a.m., shares were trading at 210.7 rupees rupees, down 7.58 percent in a weak Mumbai market.
Monday, December 20, 2010
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment